Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: S&P Capital IQ – STARS Reports
Provider: Plunkett Research, Ltd.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Allergan Inc Exploring Sale Of Obesity Business-Reuters

Tuesday, 30 Oct 2012 11:14am EDT 

Reuters reported that Allergan Inc was exploring a sale of its obesity business on falling sales of the only product in the unit. The Company expects sales of $160 million from its obesity intervention products unit for the full year. It sees total product net sales of between $5.69 billion and $5.77 billion. 

Company Quote

-1.86 -1.08%
24 Jul 2014